Insider Shareholders with Direct Ownership of Apimeds Pharmaceuticals Us, Inc. (APUS)
This section provides a comprehensive overview of the insiders with direct ownership of Apimeds Pharmaceuticals Us, Inc. (APUS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Apimeds Pharmaceuticals US, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Inscobee Inc.
> 10% Shareholder |
544,041 | 0 | 2,028,657 | 1 |
May 12, 2025
Added 2.12%
|
|
Erik C. Emerson
Chief Executive Officer |
750,000 | 0 | 750,000 | 1 |
May 16, 2025
Added 50.0%
|
|
Jakap Koo
Director |
28,500 | 0 | 643,885 | 1 |
May 12, 2025
Added 4.24%
|
|
Christopher Kim
Chairman and CMO |
277,500 | 0 | 277,500 | 3 |
May 16, 2025
Added 47.39%
|